Postnatal metabolic and reproductive consequences of fetal and neonatal exposure to the smoking cessation drug bupropion

Reproductive Sciences

Volumn 20, Issue 10, 2013, Pages 1156-1161

  De Long, Nicole ^a   Hyslop, Jillian R ^a   Nicholson, Catherine J ^a   Morrison, Katherine M ^a   Gerstein, Hertzel C ^a   Holloway, Alison C ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

cell mass; fertility; glucose homeostasis; pubertal onset

Indexed keywords

AMFEBUTAMONE; GLUCOSE;

ANIMAL EXPERIMENT; ARTICLE; BIRTH WEIGHT; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FERTILITY; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; MALE; MATING SUCCESS; METABOLISM; NONHUMAN; OBESITY; PERINATAL PERIOD; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; PUBERTY; RAT; REPRODUCTION; SMOKING CESSATION; WEIGHT GAIN;

FERTILITY; GLUCOSE HOMEOSTASIS; PUBERTAL ONSET; Β-CELL MASS;

ANIMALS; ANIMALS, NEWBORN; BUPROPION; FEMALE; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; REPRODUCTION; SMOKING CESSATION;

EID: 84883738300     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113477493     Document Type: Article

References (46)

1. Einarson A, Riordan S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol. 2009 ; 65 (4). 325-330
2. Rogers JM. Tobacco and pregnancy. Reprod Toxicol. 2009 ; 28 (2). 152-160
3. Murin S, Rafii R, Bilello K. Smoking and smoking cessation in pregnancy. Clin Chest Med. 2011 ; 32 (1). 75-91
4. Okuyemi KS, Ahluwalia JS, Harris KJ. Pharmacotherapy of smoking cessation. Arch Fam Med. 2000 ; 9 (3). 270-281
5. Benowitz NL. Nicotine addiction. N Engl J Med. 2010 ; 362 (24). 2295-2303
6. Wong S, Ordean A, Kahan M, et al. Substance use in pregnancy. J Obstet Gynaecol Can. 2011 ; 33 (4). 367-384
7. Ginzel KH, Maritz GS, Marks DF, et al. Critical review: nicotine for the fetus, the infant and the adolescent?. J Health Psychol. 2007 ; 12 (2). 215-224
8. Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010 ; 116 (2). 364-374
9. Abbott LC, Winzer-Serhan UH. Smoking during pregnancy: lessons learned from epidemiological studies and experimental studies using animal models. Crit Rev Toxicol. 2012 ; 42 (4). 279-303
10. Cressman AM, Pupco A, Kim E, Koren G. Smoking cessation therapy during pregnancy. Can Fam Physician. 2012 ; 58 (5). 525-527
11. Coleman T, Chamberlain C, Davey M-A, Cooper SE, Leonardi-Bee J.. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2012 ; (9). CD010078
12. Myung SK, Ju W, Jung HS, et al. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis. BJOG. 2012 ; 119 (9). 1029-1039
13. Rigotti NA, Park ER, Chang Y, Regan S. Smoking cessation medication use among pregnant and postpartum smokers. Obstet Gynecol. 2008 ; 111 (2 Pt 1). 348-355
14. Anderka M, Romitti PA, Sun L, et al. Patterns of tobacco exposure before and during pregnancy. Acta Obstet Gynecol Scand. 2010 ; 89 (4). 505-514
15. Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008 ; 198 (2). e1-5
16. Alwan S, Reefhuis J, Rasmussen SA, Friedman JM. National Birth Defects Prevention Study. Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol. 2011 ; 51 (2). 264-270
17. Hughes JR, Stead LF, Lancaster T.. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007 ; 1: CD000031
18. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 ; 340 (9). 685-691
19. Chan B, Einarson A, Koren G. Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis. 2005 ; 24 (2). 19-23
20. Paterson NE. Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights. Eur J Pharmacol. 2009 ; 603 (1-3). 1-11
21. Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther. 2000 ; 295 (1). 321-327
22. Somm E, Schwitzgebel VM, Vauthay DM, Aubert ML, Hüppi PS. Prenatal nicotine exposure and the programming of metabolic and cardiovascular disorders. Mol Cell Endocrinol. 2009 ; 304 (1-2). 69-77
23. Yeniceli D, Sener E, Korkmaz OT, Doǧrukol-Ak D, Tuncel N. A simple and sensitive LC-ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates. Talanta. 2011 ; 84 (1). 19-26
24. Okuyemi KS, Faseru B, Reed GA, et al. Effects of menthol on the pharmacokinetics of bupropion among Black smokers. Nicotine Tob Res. 2012 ; 14 (6). 688-693
25. Kim H, Bae SK, Park S-J, et al. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects. Br J Clin Pharmacol. 2010 ; 70 (1). 126-131
26. Bakker H, Jaddoe VWV. Cardiovascular and metabolic influences of fetal smoke exposure. Eur J Epidemiol. 2011 ; 26 (10). 763-770
27. Filion KB, Abenhaim HA, Mottillo S, et al. The effect of smoking cessation counselling in pregnant women: a meta-analysis of randomised controlled trials. BJOG. 2011 ; 118 (12). 1422-1428
28. Slotkin TA. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?. Neurotoxicol Teratol. 2008 ; 30 (1). 1-19
29. Dwyer JB, McQuown SC, Leslie FM. The dynamic effects of nicotine on the developing brain. Pharmacol Ther. 2009 ; 122 (2). 125-139
30. Pauly JR, Slotkin TA. Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Paediatr. 2008 ; 97 (10). 1331-1337
31. Winzer-Serhan UH. Long-term consequences of maternal smoking and developmental chronic nicotine exposure. Front Biosci. 2008 ; 13: 636-649
32. Bruin JE, Petre MA, Lehman MA, et al. Maternal nicotine exposure increases oxidative stress in the offspring. Free Radic Biol Med. 2008 ; 44 (11). 1919-1925
33. Cesta CE, Petrik JJ, Ambraska H, Holloway AC.. In utero and lactational exposure to nicotine alters the intra-ovarian IGF system in adult female rats. Reprod Biol Insights. 2009 ; 2: 1-9
34. Yoshikawa H, Hellström-Lindahl E, Grill V. Evidence for functional nicotinic receptors on pancreatic beta cells. Metabolism. 2005 ; 54 (2). 247-254
35. Ohtani M, Oka T, Badyuk M, Xiao Y, Kellar KJ, Daly JW. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release. Mol Pharmacol. 2006 ; 69 (3). 899-907
36. Monk C, Newport DJ, Korotkin JH, Long Q, Knight B, Stowe ZN. Uterine blood flow in a psychiatric population: impact of maternal depression, anxiety, and psychotropic medication. Biol Psychiatry. 2012 ; 72 (6). 483-490
37. Zarrindast MR, Hosseini-Nia T. Anorectic and behavioural effects of bupropion. Gen Pharmacol. 1988 ; 19 (2). 201-204
38. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010 ; 71 (10). 1259-1272
39. Woynillowicz AK, Raha S, Nicholson CJ, Holloway AC. The effect of smoking cessation pharmacotherapies on pancreatic beta cell function. Toxicol Appl Pharmacol. 2012 ; 265 (1). 122-127
40. Earhart AD, Patrikeeva S, Wang X, et al. Transplacental transfer and metabolism of bupropion. J Matern Fetal Neonatal Med. 2010 ; 23 (5). 409-416
41. Haenisch B, Bönisch H. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol Ther. 2011 ; 129 (3). 352-368
42. Piacentini MF, Clinckers R, Meeusen R, Sarre S, Ebinger G, Michotte Y. Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. J Appl Physiol. 2003 ; 95 (2). 652-656
43. Hudson AL, Lalies MD, Silverstone P. Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex. Can J Physiol Pharmacol. 2012 ; 90 (6). 803-809
44. Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol. 2000 ; 11 (3-4). 279-290
45. Cameron N, Del Corpo A, Diorio J, McAllister K, Sharma S, Meaney MJ. Maternal programming of sexual behavior and hypothalamic-pituitary-gonadal function in the female rat. PLoS ONE. 2008 ; 3 (5). e2210
46. Champagne FA. Epigenetic mechanisms and the transgenerational effects of maternal care. Front Neuroendocrinol. 2008 ; 29 (3). 386-397